Page 21234..1020..»


Category Archives: Hypogonadism

China Male Hypogonadism Market: Latest Trends, Demand and Analysis 2025 – The Think Curiouser


Posted: November 9, 2020 at 3:53 pm

Market Overview of China Male Hypogonadism Market The China Male Hypogonadism market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. The global China Male Hypogonadism market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2795970&source=atm Market segmentation China Male Hypogonadism market is split by Type and by Application Continue reading

Posted in Hypogonadism | Comments Off on China Male Hypogonadism Market: Latest Trends, Demand and Analysis 2025 – The Think Curiouser

Global Hypogonadism Drug Market Business Share, Industry Size and Future Investment Opportunities by 2026||ALLERGAN, AstraZeneca, Bayer AG., Eli Lilly…


Posted: November 9, 2020 at 3:53 pm

Global hypogonadism drug marketis rising gradually with a substantial CAGR in the forecast period of 2019-2026. Continue reading

Posted in Hypogonadism | Comments Off on Global Hypogonadism Drug Market Business Share, Industry Size and Future Investment Opportunities by 2026||ALLERGAN, AstraZeneca, Bayer AG., Eli Lilly…

Aytu BioScience to Report First Quarter Fiscal 2021 Results and Provide Business Update on Thursday, November 12, 2020 – Yahoo Finance


Posted: November 9, 2020 at 3:53 pm

Live Conference Call and Webcast at 4:30 PM ET ENGLEWOOD, CO / ACCESSWIRE / November 5, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that the Company will present its operational results for the fiscal first quarter ended September 30, 2020 on November 12, 2020, at 4:30 p.m. ET. Continue reading

Posted in Hypogonadism | Comments Off on Aytu BioScience to Report First Quarter Fiscal 2021 Results and Provide Business Update on Thursday, November 12, 2020 – Yahoo Finance

Testosterone Replacement Therapy Market | Latest Trends and Revenues Analysis Report – BioSpace


Posted: November 1, 2020 at 5:59 pm

The global testosterone replacement therapy market is expected to be influenced by the rising awareness about the diseases itself. There has been a rise in the incidences of hypogonadism, which has resulted in several companies to make an introduction of various awareness campaigns so as to encourage people to come out for early diagnosis of the disease. The surge in the emergence of novel therapeutic approaches has become an emerging trend, which is further expected to stimulate growth of the global testosterone replacement therapy market over the timeframe of analysis, from 2019 to 2029. Continue reading

Posted in Hypogonadism | Comments Off on Testosterone Replacement Therapy Market | Latest Trends and Revenues Analysis Report – BioSpace

EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Alkindi and Submits Market…


Posted: October 22, 2020 at 5:57 pm

Oct. Continue reading

Posted in Hypogonadism | Comments Off on EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Alkindi and Submits Market…

Male Hypogonadism Therapy Market is Booming Worldwide By Top Key Players: Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva,…


Posted: October 17, 2020 at 8:49 am

LOS ANGELES, United States: QY Research has recently published a research report titled, Global Male Hypogonadism Therapy Market Size, Status and Forecast 2020-2026. This report has been prepared by experienced and knowledgeable market analysts and researchers Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Therapy Market is Booming Worldwide By Top Key Players: Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva,…

Share tips of the week – MoneyWeek


Posted: October 17, 2020 at 8:48 am

Three to buyDiurnal Group (The Sunday Times)This Aim-listed drug developer is one of only a handful of drug firms on Londons junior market that already has a product on the market: Alkindi, a treatment for adrenal insufficiency. The firm is now conducting early stage trials of another drug, Ditest, a possible treatment for hypogonadism that has blockbuster potential. The business is likely to remain loss-making until 2023, but Diurnal looks like a winner Continue reading

Posted in Hypogonadism | Comments Off on Share tips of the week – MoneyWeek

Harvard Study Shows That Flavonoids Could Prevent Erectile Dysfunction – Gilmore Health News


Posted: October 17, 2020 at 8:48 am

A study conducted jointly by Harvard University and the University of East Anglia in England showed that a flavonoid-rich diet can help reduce the risk of erectile dysfunction, which is a common condition in older men. Berries The properties of exercise to prevent erectile dysfunction are already known, but this is the first time that a study has examined flavonoid-rich nutrition in conjunction with exercise as a countermeasure to erectile dysfunction in older men. Flavonoids are naturally occurring antioxidant substances in foods and beverages of plant origin such as fruits and vegetables, tea, and even wine Continue reading

Posted in Hypogonadism | Comments Off on Harvard Study Shows That Flavonoids Could Prevent Erectile Dysfunction – Gilmore Health News

Latest Report By QYResearch on Hormone Replacement Therapy (HRT) Market Trend, Overview, Competitor Analysis, Growth by 2026 – Weekly Wall


Posted: October 9, 2020 at 3:50 am

Los Angeles, United State, The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Hormone Replacement Therapy (HRT) market. It includes Porters Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Hormone Replacement Therapy (HRT) Market. We have provided deep analysis of the vendor landscape to give you a complete picture of current and future competitive scenarios of the global Hormone Replacement Therapy (HRT) market. Continue reading

Posted in Hypogonadism | Comments Off on Latest Report By QYResearch on Hormone Replacement Therapy (HRT) Market Trend, Overview, Competitor Analysis, Growth by 2026 – Weekly Wall

Covid-19 could lower testosterone levels and libido in men – heres what the new study found – Derry Journal


Posted: October 9, 2020 at 3:50 am

A new study has revealed that men who contracted Covid-19 have their testosterone levels lowered by 30 per cent, on average. Even two thirds of men who showed no symptoms reported a loss of libido. Researchers in Turkey analysed levels of sex hormone in 232 men who were hospitalised after they tested positive for Covid-19. Continue reading

Posted in Hypogonadism | Comments Off on Covid-19 could lower testosterone levels and libido in men – heres what the new study found – Derry Journal

Page 21234..1020..»